Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Recruiting

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(34 sites)

United States

A40, Tucson, Arizona

A13, Carlsbad, California

A46, Los Angeles, California

A14, Orange, California

A21, Aurora, Colorado